Pfizer is one of the highest-yielding stocks in the S&P 500 right now, which sounds good until you realize why - the stock has been the worst performer among big pharma names this year and the earnings outlook keeps getting weaker. They can't stop cutting jobs, another 370 in Italy just got the notice this month. The yield is theoretically great, but the stock has gone nowhere and management keeps talking about 2029 like that's when things finally get better. That's a long wait.
There are no replies in this thread yet. Be the first to post a reply below: